What defines a listed drug product under ODBA?

A listed drug product under the Ontario Drug Benefit Act (ODBA) is specifically defined as a combination of drugs in a specific dosage form and strength. This definition is crucial because it reflects the regulatory framework that qualifies medications for coverage under the provincial drug benefit plan.

Listing a drug requires it to meet certain criteria, ensuring that the medications provided under the ODBA are standardized and effective for treatment. By focusing on both the combination and the specific dosage form and strength, the ODBA can maintain a consistent level of quality and efficacy in the medications it covers.

This classification is essential for healthcare professionals to understand when making prescribing decisions and for patients to be aware of the medications that are financially supported by the provincial healthcare system. It also differentiates listed drugs from others which might not meet these requirements, emphasizing the importance of formulation and strength in the context of drug benefits under Ontario's healthcare policies.